Azienda Ospedaliero-Universitaria

Cagliari 09124

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced or Metastatic and Unresectable HCC, Metastatic Breast Cancer

Studies at this site

• A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC — Completed
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed